0
0
Understanding the Multi-Species Glucose Monitoring Challenge
Veterinary professionals responsible for cats, dogs, rabbits, and rats face a recurring operational question: how to obtain fast, dependable blood glucose readings across different animal physiologies while working with limited fresh venous or capillary whole blood samples. Point-of-care testing in a clinical or home-care setting depends on instruments that can process small samples quickly and deliver results clinicians can act on without delay. This is precisely the category of need that VivaChek Biotech (Hangzhou) Co., Ltd. addresses through its broader point-of-care testing (POCT) portfolio, which extends from human diabetes management into veterinary diagnostics.
VivaChek Biotech: A Company Built Around Accessible Health Management
Founded in August 2013 and headquartered at Building 2, No.17 Wuzhou Road, Donghu Street, Linping District, Hangzhou, Zhejiang, People's Republic of China, VivaChek Biotech operates under the development concept of "making health management accessible." The company has structured its business around an ecosystem it describes as "chronic disease management + rapid diagnosis + digital medical," with the stated aim of becoming a globally trusted smart POCT provider. As a high-tech enterprise and POCT product manufacturer, VivaChek's products are currently available in over 120 countries, and the company's blood glucose meters have helped millions of diabetic patients worldwide manage their condition. This scale of deployment reflects a manufacturing and quality infrastructure that also underpins the company's veterinary diagnostic offerings.
Veterinary Diagnostics Within the VivaChek Product Matrix
Veterinary diagnostics is explicitly listed among the industries VivaChek covers, with veterinary professionals identified as a core customer type. Within this line, the company's veterinary portfolio includes a dedicated Blood Glucose Monitoring System, alongside a Blood Ketone Monitoring System, a Milk Ketone Monitoring System, and the Veterinary Coagulation and Chemistry Combo with its accompanying analyzer. Together these products form a monitoring ecosystem intended to support blood glucose, ketone, and broader metabolic and coagulation testing needs in animal health settings — the same categories of point-of-care testing that veterinary teams managing cats, dogs, rabbits, and rats rely on for day-to-day case management.
Technology Foundation Behind the Testing Systems
VivaChek's technology platform is built on several core capabilities that support its diagnostic instruments. The company applies biosensor technology for glucose, ketone, and uric acid monitoring across its product lines, the same underlying sensor discipline that informs its human glucose meters and extends into its veterinary blood glucose and ketone systems. For more complex veterinary panels, VivaChek uses a centrifugal microfluidic platform specifically for coagulation and chemistry testing, as implemented in the Veterinary Coagulation and Chemistry Combo. This system is designed to work with lyophilized reagents stored at 2-8°C with a 12-month shelf life, and it processes samples of whole blood, plasma, or serum. Documented performance figures include a sample volume of 140 μL for chemistry testing and 180 μL for coagulation testing, with results delivered in ≤13 minutes for chemistry and ≤15 minutes for coagulation. These figures illustrate the company's engineering approach: minimizing sample volume and turnaround time so that time-sensitive diagnostic decisions can be made at the point of care rather than after sending samples to an external laboratory.
On the human diagnostics side, VivaChek's glucose monitoring technology has demonstrated a hematocrit range of 0-70% in its VivaChek Neo System, supporting testing across diverse patient profiles including neonates, pregnant women, and patients with anemia. While this particular hematocrit specification is documented for human use, it reflects the same sensor engineering philosophy — accommodating variation in blood sample characteristics — that carries through the company's broader biosensor-based product design, including its multi-function monitoring systems that combine glucose, ketone, and uric acid testing in a single device such as the VivaChek X system.
Quality Systems Supporting Every Product Category
Across its portfolio, VivaChek maintains a quality management system aligned with multiple international frameworks: China GMP, the international ISO system, FDA QSR (Quality System Regulations), FDA 510(k) clearance, European Union CE marking, China NMPA registration, and EN ISO 13485. For its human blood glucose meters, specifically the VivaChek Ino and VivaChek Eco models, the company documents compliance with DIN EN ISO 15197:2013 requirements — the recognized accuracy standard for self-monitoring blood glucose systems. This layered certification structure gives veterinary customers visibility into the same manufacturing and quality discipline that governs VivaChek's broader diagnostic device lineup, even as species-specific product documentation for the veterinary Blood Glucose Monitoring System is maintained separately from the human-use certifications listed above.
A Global Manufacturing and Distribution Footprint
VivaChek's veterinary and human diagnostic products are supported by a global operational structure. The company's headquarters and primary operations are based in Hangzhou, Zhejiang, with a manufacturing facility located in Shaoxing, Zhejiang Province. International presence includes Vivachek Diagnostics Inc. in Sacramento, California; VivaChek Laboratoires, Inc. in Wilmington, Delaware; VivaChek Life Care in Chennai, India; and dedicated Singapore and India branches. This distributed footprint has supported the company's growth from initial sales in more than 30 countries within its first year following product launch to a current presence in over 120 countries. VivaChek has also engaged directly with the international medical device community through participation in exhibitions including FIME, CMEF, MEDICA, Arab Health, EASD, Medtrade, MEDICAL FAIR THAILAND, SFD, and MEDIALAB Asia Pacific between 2014 and 2019, including exhibition support tied to World Diabetes Day awareness activities.
What This Means for Veterinary Practices
For clinics and animal health facilities testing glucose levels in cats, dogs, rabbits, or rats, VivaChek's veterinary Blood Glucose Monitoring System sits within a broader ecosystem that also includes ketone and milk ketone monitoring, plus coagulation and chemistry testing through the centrifugal microfluidic Combo platform. Rather than functioning as an isolated device, it is positioned as part of a company-wide capability built on biosensor technology, documented quality certifications spanning FDA, CE, and NMPA frameworks, and a global manufacturing and support network spanning Asia, North America, and India. Veterinary teams evaluating point-of-care glucose testing options can view VivaChek Biotech's veterinary line as an extension of a diagnostics company whose core technology and quality infrastructure were established to serve accessible health management needs across both human and animal care contexts.
https://www.vqpet.com/products/vqpet-h/index.html
VivaChek Biotech (Hangzhou) Co., Ltd.
Average Rating